Alexium Accelerates Manufacturing Scale-Up Post-Microtek Acquisition with $1.03M Sales
Alexium International Group has boosted sales to $1.03 million following its Microtek Laboratories acquisition, shifting focus to manufacturing-led growth and expanding its flame-retardant and thermal regulation product lines.
- Microtek acquisition drives sales growth to $1.03 million
- Shift to manufacturing-centred business model underway
- Expanded product applications in flame-retardant and thermal regulation
- Funding strengthened by $4.6 million entitlement offer and shareholder loans
- Operational efficiency improvements and phased capacity expansion planned
Sales Boost from Microtek Acquisition and Product Diversification
Alexium International Group Limited (ASX:AJX) reported a notable jump in quarterly sales to $1.03 million, up from $794,000 in the prior quarter, largely due to the late January acquisition of Microtek Laboratories. This deal has not only expanded Alexium's customer base but also diversified its product portfolio beyond its core microencapsulated phase change materials (mPCM) technology to include flame-retardant coatings and dehumidification textiles. The company highlighted new placements in mPCM coatings and emerging opportunities in non-bedding markets such as furniture and building materials, signalling a broader addressable market for its thermal regulation products.
Building on its historical focus on textile applications, Alexium is now also targeting foam bedding markets internationally, leveraging the combined manufacturing capabilities from the Microtek integration. This expanded footprint is expected to ramp throughout calendar year 2026, with new mPCM business commencing in Q3 and promising growth potential from adjacent markets acquired with Microtek. The company's flame-retardant technology, branded AlexiShield, is positioned to benefit from geopolitical factors driving demand for US-produced materials, especially in bedding, furniture, and transportation sectors.
Manufacturing-Centred Model and Operational Efficiency Gains
The Microtek acquisition marks a strategic pivot for Alexium from a technology developer reliant on outsourced production to a manufacturing-centred business. This transition is already yielding operational improvements, with the successful merger of Nextek and AlexiPCM mPCM processes creating a more efficient and cost-effective platform. Pilot-scale tests demonstrated major gains in yield and throughput, with plans to implement these improvements in the coming quarter. The company is also addressing equipment uptime through enhanced maintenance and minor upgrades, while drafting workforce training programs to foster a productive culture across the merged operations.
Alexium has outlined a phased capacity expansion strategy prioritising labour utilisation before capital expenditure. The immediate focus is on maximizing existing asset efficiency at the Dayton, Ohio facility, followed by scaling production through incremental manpower additions, including recruiting for a fractional second shift. A full 24x7 operating model remains on hold pending successful ramp-up of the second shift. This disciplined approach aims to balance capital efficiency with responsiveness to customer demand, deferring major capital investments until labour-based capacity is fully exploited.
Funding Structure Supports Growth Amid Cash Flow Challenges
Financially, Alexium maintains a $3 million asset-based line of credit with Alterna Capital Solutions, with $513,000 drawn against a $610,000 borrowing base as of March 31, 2026. To supplement working capital, the company secured $3.1 million in shareholder loans from Colinton Capital Partners and Wentworth Williamson Management, with $1 million committed during Q2 FY26. The recent entitlement offer raised $4.6 million gross, of which $3.1 million was used to reduce shareholder loan balances, leaving $1.4 million for acquisition-related expenses and working capital during the manufacturing transition.
Despite increased sales, cash receipts fell to $692,000 due to timing differences between sales and payment cycles. Operating cash outflows remain significant at $1.458 million for the quarter, reflecting ongoing investment in raw materials, manufacturing, staffing, and corporate costs. Alexium estimates available funding covers approximately 0.6 quarters at current operating cash burn, but management expresses confidence in continued shareholder support and anticipated sales growth from new and existing opportunities.
Military and Technical Workwear Markets Poised for Near-Term Catalysts
On the commercial front, Alexium is advancing its AlexiFlam flame-resistant textile project targeting the US military uniform supply chain. The company is in the penultimate phase of testing treated fabrics sewn into uniforms for field trials scheduled in 2026. Successful limited user evaluations could lead to Requests for Proposals and subsequent contracts. While engagements with technical workwear fabric providers show promise, investment in this segment is currently paused to focus resources on military uniforms and bedding markets.
These developments build on the company's earlier strategic moves, including the Microtek acquisition enhances manufacturing and the $4.6 million entitlement offer that strengthened its balance sheet. The integration of Microtek's manufacturing capabilities and customer relationships is central to Alexium's ambition to deliver profitable growth and shareholder value through a diversified product suite and manufacturing scale-up.
Bottom Line?
Alexium’s manufacturing pivot is gaining traction, but the coming quarters will test its ability to convert operational improvements and expanded sales pipelines into sustained cash flow and profitability.
Questions in the middle?
- Can Alexium successfully ramp second-shift operations to meet growing customer demand?
- Will military uniform field trials translate into significant contract wins in 2026?
- How will minor capital projects planned for CY26 impact the company’s cash flow and margins?